Addressing the Zika Virus Threat to the US Blood Supply by NAT

Description:

Course Overview

 

Course Quality Rating

TBD

Course Description

This course is provided by Association of Public Health Laboratories and will require a secondary login and/or registration.

This archived webinar is presented by Jeffrey M. Linnen, PhD, Associate Vice-President, R&D. Hologic Inc., San Diego, CA. In the last year, Zika virus has rapidly spread in South and Central America and could be a real threat to transfusion blood and blood components in the US and its territories. This program will discuss the performance characteristics of an investigational nucleic acid test (NAT) for Zika virus RNA along with an update on NAT blood screening for Zika virus in the US under an Investigational New Drug (IND) protocol. Costs: $25/person includes limited access and CEUs for one person.                                                                                                     

Click the LAUNCH button below to start or be taken to the course.

Target Audience

This archived webinar is designed for laboratorians.

Learning Objectives

Having completed this archived webinar, the learner will be able to: 

  1. Explain the role of nucleic acid testing in reducing the risk of Zika virus transfusion transmission

Council of Linkages Core Competencies for Public Health Professionals (COL)/COL Tier(s)

None listed

Professional/Disciplinary Competencies

None listed 

Format

Archived Webinar

Credit /CEU

Approved for 1.0 P.A.C.E. ®, Florida or CPH-Recertification Credit; CEUs accepted by all licensure states.

Duration

None listed 

Specifications

None listed 

Course Publication Date

September 22, 2016

Launch